Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 5Gastrointestinal 2Dermatologic 2Breast 2Thoracic 1Other solid neoplasm 1Other hematologic neoplasm 1Other 1NET 1Endocrine 1

Conditions

Acute Graft Versus Host Disease 1

Interventions

Exercise 27Metformin 20Surveys and Questionnaires 19Methods 14Educational Status 12Early Intervention, Educational 11Counseling 11Tirzepatide 9Standard of Care 9Nutrition Assessment 9Diet Therapy 9Resistance Training 8Radiotherapy 8Diet 8Interviews as Topic 7Liraglutide 6semaglutide 5Radiation 5Low-Level Light Therapy 5Exenatide 5Diet, Mediterranean 5Dexamethasone 5Cryotherapy 5Caloric Restriction 5Blood Specimen Collection 5Bariatric Surgery 5Vitamin D 4Therapeutics 4Sugars 4Specimen Handling 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Leflunomide × Other × Clear all
NCT05443425 2025-07-04

Leflunomide in Combination With Steroids for the Treatment of Acute Graft-versus-Host Disease After Donor Stem Cell Transplant for Hematologic Malignancies

City of Hope Medical Center

Phase 1 Recruiting
18 enrolled
Other

Acute Graft Versus Host Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡